In particular, we found that circulating human ANGPTL8 levels were positively correlated with obesity and dyslipidemia, as estimated by increased TG and LDL-cholesterol levels and decreased HDL-cholesterol levels, suggesting that circulating ANGPTL8 concentrations predict future CVD development. This evidence concerns the gene ANGPTL8 and metabolic syndrome.